Abstract:The combination of multi-targeting magnetic nanoprobes and multi-targeting strategies has potential to facilitate magnetic resonance imaging (MRI) and magnetic induction hyperthermia of the tumor. Although the thermo-agents based on magnetic iron oxide nanoparticles (MION) have been successfully used in the form of intratumoral injection in clinical cure of glioblastoma, the tumor-targeted thermotherapy by intravenous administration remains challenging. Herein, we constructed a c(RGDyK)- and d-glucosamine-grafted bispecific molecular nanoprobe (Fe3O4@RGD@GLU) with a magnetic iron oxide core of size 22.17 nm and a biocompatible shell of DSPE-PEG2000, which can specially target the tumor vessel and cancer cells. The selection of c(RGDyK) could make the nanoprobe enter the neovascularization endotheliocyte through αvβ3-mediated endocytosis, which drastically reduced the dependence on the enhanced permeability and retention (EPR) effect in tumor. This dual-ligand nanoprobe exhibited strong magnetic properties and favorable biocompatibility. In vitro studies confirmed the anti-phagocytosis ability against macrophages and the specific targeting capability of Fe3O4@RGD@GLU. Then, the imaging effect and anti-tumor efficacy were compared using different targeting strategies with untargeted nanoprobes, dual-targeted nanoprobes, and magnetic targeting combined with dual-targeted nanoprobes. Moreover, the combination strategy of magnetic targeting and active targeting promoted the penetration depth of nanoprobes in addition to the increased accumulation in tumor tissue. Thus, the dual-targeted magnetic nanoprobe together with the combined targeting strategy could be a promising method in tumor imaging and hyperthermia through in vivo delivery of theranostic agents. STATEMENT OF SIGNIFICANCE: Magnetic induction hyperthermia based on iron oxide nanoparticles has been used in clinic for adjuvant treatment of recurrent glioblastoma. Nonetheless, this application is limited to intratumoral injection, and tumor-targeted hyperthermia by intravenous injection remains challenging. In this study, we developed a multi-targeted strategy by combining magnetic targeting with active targeting of dual-ligand magnetic nanoprobes. This combination mode acquired optimum contrast imaging effect through MRI and tumor-suppressive effect through hyperthermia under an alternating current magnetic field. The design of the nanoprobe was suitable for targeting most tumor lesions, which enabled it to be an effective theranostic agent with extensive uses. This study showed significant enhancement of the penetration depth and accumulation of nanoprobes in the tumor tissue for efficient imaging and hyperthermia.

Using PEGylated Magnetic Nanoparticles to Describe the EPR Effect in Tumor for Predicting Therapeutic Efficacy of Micelle Drugs

Preparation and Evaluation of Neovessel-targeted Paramagnetic PEGylated Liposome

Effective PEGylation of Fe<SUB>3</SUB>O<SUB>4</SUB> Nanomicelles for <i>in Vivo</I> MR Imaging

Nonclustered magnetite nanoparticle encapsulated biodegradable polymeric micelles with enhanced properties for in vivo tumor imaging

Micelle-like Nanoparticles for Drug Delivery and Magnetically Enhanced Tumor Chemotherapy

Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy

PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: Potential theranostic applications and in vivo toxicity studies

Magnetic Brain Tumor Targeting and Biodistribution of Long-Circulating PEG-modified, Cross-Linked Starch-Coated Iron Oxide Nanoparticles

Engineering Magnetic-Molecular Sequential Targeting Nanoparticles for Anti-Cancer Therapy.

A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG As Tumor-Targeted MRI Contrast Agent

Effective Pegylation of Iron Oxide Nanoparticles for High Performance in Vivo Cancer Imaging

Magnetic Resonance Imaging-Visible and Ph-Sensitive Polymeric Micelles for Tumor Targeted Drug Delivery

Enhanced Tumor Targeting Effects of a Novel Paclitaxel-Loaded Polymer: PEG–PCCL-modified Magnetic Iron Oxide Nanoparticles

Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics

Magnetic Targeting Combined with Active Targeting of Dual-Ligand Iron Oxide Nanoprobes to Promote the Penetration Depth in Tumors for Effective Magnetic Resonance Imaging and Hyperthermia.

Actively-targeted LTVSPWY Peptide-Modified Magnetic Nanoparticles for Tumor Imaging

Enhancing MRI imaging through high loading of superparamagnetic nanogels with high sensitivity to the tumor environment

Novel Approach of Using Near-Infrared Responsive PEGylated Gold Nanorod Coated Poly(l-lactide) Microneedles to Enhance the Antitumor Efficiency of Docetaxel-Loaded MPEG-PDLLA Micelles for Treating an A431 Tumor

Magnetic Iron Oxide Nanoparticles/10-Hydroxy Camptothecin Co-Loaded Nanogel for Enhanced Photothermal-Chemo Therapy

Tumor Microenvironment-Responsive Multifunctional Nanoplatform Based on MnFe2O4-PEG for Enhanced Magnetic Resonance Imaging-Guided Hypoxic Cancer Radiotherapy

Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy